BASF to Develop a High Purity Poloxamer for Mast Therapeutics

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/25/2026

1. MU
2. QCOM
3. SPY
4. JPM
5. ICLR
6. USO
7. FUL
8. LAES
9. AAPL

Go back to BASF to Develop a High Purity Poloxamer for Mast Therapeutics
MAST THERAPEUTICS, Inc. (NASDAQ: MSTX) Delayed: 7.33 -1.68 (18.65%)
Previous Close $9.01    52 Week High $0.71 
Open $9.10    52 Week Low $0.07 
Day High $9.10    P/E N/A 
Day Low $7.26    EPS $-0.35 
Volume 11,554,498       

MAST THERAPEUTICS, Inc. (NASDAQ: MSTX) Delayed: 7.33 -1.68 (18.65%)
Previous Close $9.01    52 Week High $0.71 
Open $9.10    52 Week Low $0.07 
Day High $9.10    P/E N/A 
Day Low $7.26    EPS $-0.35 
Volume 11,554,498